• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Dead Wrong: Deceased Patients Continue To Receive Healthcare Notifications and Reminders

News
Article

Electronic health records often do not record when someone has died. The deceased continue to get a variety of healthcare reminders.

@ Rawf8  stock.adobe.com

@ Rawf8 stock.adobe.com

A substantial number of deceased patients continue to receive correspondence from their providers, according to a research letter published today in JAMA Internal Medicine.

The researchers found that one-quarter of the the almost 12,000 patients in a previous study of seriously ill primary care patients had died and were recorded as being deceased in a University of California healthcare system's electronic health record (EHR). But 676 (5.8%) of those who had died were still recorded as being alive in the EHR. Among those, 541 (80%) continued to be contacted. They received 221 telephone calls, 338 portal messages and 920 letters concerning unmet primary care needs such as reminders for cancer screenings. There were also 184 vaccine orders. Medications were authorized in 130 instances.

"Not knowing who is dead hinders efficient health management, billing, advanced illness interventions, and measurement," wrote corresponding author Neil S. Wenger, M.D., M.P.H., of the UCLA Division of General Internal Medicine and Health Services Research, and his colleagues. "It impedes the health system’s ability to learn from adverse outcomes, to implement quality improvement, and to provide support for families."

States keep track of deaths, but that information doesn't reach healthcare systems. Wenger and his colleagues note that the National Association for Public Health Statistics and Information Systems maintains a real-time fact of death service, but providers have been unable to use it.

Related Videos
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Video 8 - "Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization"
Video 7 - "Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider"
Related Content
© 2024 MJH Life Sciences

All rights reserved.